Cita APA

Kamonrattana, R., Sathitsamitphong, L., Choeyprasert, W., Charoenkwan, P., Natesirinilkul, R., & Fanhchaksai, K. (2019). A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. Asian Pac J Cancer Prev.

Chicago Style Citation

Kamonrattana, Ruchirek, Lalita Sathitsamitphong, Worawut Choeyprasert, Pimlak Charoenkwan, Rungrote Natesirinilkul, i Kanda Fanhchaksai. "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients." Asian Pac J Cancer Prev 2019.

Cita MLA

Kamonrattana, Ruchirek, et al. "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients." Asian Pac J Cancer Prev 2019.